Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Generex Biotechnology Corp. (GNBTQ) Message Board

I emailed Todd yesterday and he called. Todd is v

Message Board Public Reply | Private Reply | Keep | Replies (3)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 36566
(Total Views: 292)
Posted On: 05/15/2020 10:27:12 AM
Posted By: hoops
I emailed Todd yesterday and he called. Todd is very detailed in explaining very little. That's his job. However, my take is that the big hurdle is approval of the S-1. Generex is borrowing bits of money to keep the lights on, but uplisting, the NGIO dividends, possible purchases, and R&D are dependent on funds from the S-1. MMPJoe has refused more toxic forms of funding that have been offered.

A lot of work went into the BARDA application and Todd believed it was well written. Application for COVID-19 funds from other companies have been made. Maybe Canada?

Joe is working his hardest to get the initiatives completed, but it just can't be done without money. He could not tell my why the S-1 has been held up, or if it has been held up at all. Perhaps all things Washington have been set back due to COVID-19 (JMO).

10-Q may reflect some earnings, but I didn't get the impression they would blow the doors off. No update available regarding Zhonghong COVID deal. Should some of their entities show they can survive on their own, they may be spun off. Todd said this was in the 10-K, but I missed it.

I think we can assume that no PR's will be issued unless there is something significant to report. When S-1 is approved, subsequent movement with the other initiatives should be rapid.

That's the best that I can recall from a verbal conversation. It's difficult to remember everything that was discussed. Take away is S-1, S-1, S-1. That is not to say other things aren't happening and other sources of funding have not been explored, but any real news we expect is going to be contingent upon approval of the S-1.


(5)
(0)




Generex Biotechnology Corp. (GNBTQ) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us